Results
|
1.
|
Amplification of USP13 drives non-small cell lung cancer progression mediated by AKT/MAPK signaling. [electronic resource] by
- Wu, Yue
- Zhang, Yingqiu
- Liu, Congcong
- Zhang, Yang
- Wang, Duchuang
- Wang, Shanshan
- Wu, Yueguang
- Liu, Fang
- Li, Qiong
- Liu, Xiuxiu
- Zaky, Mohamed Y
- Yan, Dong
- Liu, Shuyan
Producer: 20190829
In:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 114
Availability: No items available.
|
|
2.
|
Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects. [electronic resource] by
- Xu, Lu
- Zhang, Yang
- Tian, Kang
- Chen, Xi
- Zhang, Rongxin
- Mu, Xindi
- Wu, Yueguang
- Wang, Duchuang
- Wang, Shanshan
- Liu, Fang
- Wang, Taishu
- Zhang, Jinrui
- Liu, Shuyan
- Zhang, Yingqiu
- Tu, Caixia
- Liu, Han
Producer: 20190109
In:
Journal of experimental & clinical cancer research : CR vol. 37
Availability: No items available.
|
|
3.
|
The exon 19-deleted EGFR undergoes ubiquitylation-mediated endocytic degradation via dynamin activity-dependent and -independent mechanisms. [electronic resource] by
- Wang, Taishu
- Zhang, Jinrui
- Wang, Shanshan
- Sun, Xiuna
- Wang, Duchuang
- Gao, Yurou
- Zhang, Yang
- Xu, Lu
- Wu, Yue
- Wu, Yueguang
- Liu, Fang
- Liu, Xiuxiu
- Liu, Shuyan
- Zhang, Yingqiu
- Wang, Yang
- Zou, Lijuan
- Liu, Han
Producer: 20190513
In:
Cell communication and signaling : CCS vol. 16
Availability: No items available.
|
|
4.
|
Dynasore-induced potent ubiquitylation of the exon 19 deletion mutant of epidermal growth factor receptor suppresses cell growth and migration in non-small cell lung cancer. [electronic resource] by
- Wang, Taishu
- Wang, Duchuang
- Zhang, Yue
- Zhang, Jinrui
- Sun, Xiuna
- Wu, Yue
- Wang, Shanshan
- Zhang, Yang
- Xu, Lu
- Kong, Qingxia
- Gao, Yurou
- Wu, Yueguang
- Liu, Fang
- Liu, Shuyan
- Zhang, Yingqiu
- Lei, Ting
- Liu, Han
Producer: 20190610
In:
The international journal of biochemistry & cell biology vol. 105
Availability: No items available.
|
|
5.
|
Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer. [electronic resource] by
- Zhang, Jinrui
- Li, Qiong
- Wu, Yueguang
- Wang, Duchuang
- Xu, Lu
- Zhang, Yang
- Wang, Shanshan
- Wang, Taishu
- Liu, Fang
- Zaky, Mohamed Y
- Hou, Shuai
- Liu, Shuyan
- Zou, Kun
- Lei, Haixin
- Zou, Lijuan
- Zhang, Yingqiu
- Liu, Han
Producer: 20190612
In:
Cell communication and signaling : CCS vol. 17
Availability: No items available.
|
|
6.
|
Dynasore potentiates c-Met inhibitors against hepatocellular carcinoma through destabilizing c-Met. [electronic resource] by
- Zaky, Mohamed Y
- Liu, Xiuxiu
- Wang, Taishu
- Wang, Shanshan
- Liu, Fang
- Wang, Duchuang
- Wu, Yueguang
- Zhang, Yang
- Guo, Dong
- Sun, Qianhui
- Li, Qiong
- Zhang, Jinrui
- Zhang, Yingqiu
- Dong, Weijie
- Liu, Zhenhua
- Liu, Shuyan
- Liu, Han
Producer: 20200511
In:
Archives of biochemistry and biophysics vol. 680
Availability: No items available.
|
|
7.
|
Endocytic degradation of ErbB2 mediates the effectiveness of neratinib in the suppression of ErbB2-positive ovarian cancer. [electronic resource] by
- Wang, Shanshan
- Zhang, Jinrui
- Wang, Taishu
- Ren, Feng
- Liu, Xiuxiu
- Lu, Yongqi
- Xu, Linying
- Zhang, Yang
- Wang, Duchuang
- Xu, Lu
- Wu, Yueguang
- Liu, Fang
- Li, Qiong
- Zaky, Mohamed Y
- Liu, Shuyan
- Dong, Weijie
- Liu, Fang
- Zou, Kun
- Zhang, Yingqiu
Producer: 20200611
In:
The international journal of biochemistry & cell biology vol. 117
Availability: No items available.
|